Login / Signup

A microchip flow-chamber assay screens congenital primary hemostasis disorders.

Yuto NakajimaKoji YadaKenichi OgiwaraShoko FurukawaNaruto ShimonishiMidori ShimaKeiji Nogami
Published in: Pediatrics international : official journal of the Japan Pediatric Society (2020)
T-TAS with PL-chip could be a quick screening tool for congenital primary hemostasis disorder, VWD, and PFDs.
Keyphrases
  • high throughput
  • genome wide
  • gene expression
  • dna methylation